发明名称 COMPOSITION IN WHICH PROBIOTICS STRAIN GM-263 (ADR-1) IS USED FOR TREATING KIDNEY FIBROSIS CAUSED BY DIABETES AND USE THEREOF
摘要 <P>PROBLEM TO BE SOLVED: To effectively treat kidney fibrosis caused by diabetes. <P>SOLUTION: There are provided a composition of probiotics strain GM-263 (ADR-1) on the treatment of kidney fibrosis caused by diabetes, and uses thereof. An effective content of Lactobacillus reuteri GM-263 (ADR-1) (accession number: CCTCC M 209263) is used to prepare the composition for treating kidney fibrosis caused by diabetes. The composition lowers the concentrations of glycosylated hemoglobin and blood sugar, recovers body weight and kidney weight in normal ranges, further specifically inhibits a JAK2/STAT1 signal transmission route, and inhibits the expression of a protein related to kidney fibrosis. Thus, the kidney fibrosis caused by the diabetes is effectively treated. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012149026(A) 申请公布日期 2012.08.09
申请号 JP20110019444 申请日期 2011.02.01
申请人 GENMONT BIOTECH INC 发明人 LU YING-CHEN;HUANG JAUSHYANG;HSIEH FENG-CHING;LI YICHENG;LEE CHIALIN
分类号 A61K35/74;A23L1/30;A61P3/10;A61P13/12;A61P43/00;C12N1/20 主分类号 A61K35/74
代理机构 代理人
主权项
地址